FineHeart Achieves Milestone For its Miniaturized Heart Pump Technology with Successful Completion of 30-Day Preclinical Study

This in vivo study is a significant milestone as we work towards first-in-human clinical trials and prove ICOMS technology as a potential game-changer in saving patients from heart failure

Arnaud Mascarell

Founder & Chief Executive Officer

Version Française

Fineheart-CP-20.10.20-VDEF

English version

Fineheart-PR-20.10.20-FINAL